Study of Efficacy of Ranibizumab in Different Regimens in Patients With Diabetic Macula Edema
Status:
Completed
Trial end date:
2017-06-08
Target enrollment:
Participant gender:
Summary
The purpose of this study was to demonstrate that the change of best corrected visual acuity
(BCVA) was comparable in patients treated with ranibizumab at the discretion of the
investigator vs. treatment according to a standard of care scheme (pro re nata, as needed).